Subject(s)
Anti-Infective Agents , COVID-19 , Clostridium Infections , Humans , Clostridium Infections/epidemiologyABSTRACT
No disponible
Subject(s)
Humans , Male , Adolescent , Hemangioma/complications , Hemangioma/diagnosis , Upper Extremity/pathology , Skin Neoplasms/diagnosis , Skin Neoplasms/pathology , Diagnosis, Differential , Arteriovenous Malformations/pathology , Arteriovenous Malformations , Immunohistochemistry/instrumentation , Immunohistochemistry/methods , Immunoglobulin E/analysis , AngiographyABSTRACT
No disponible
Subject(s)
Humans , Male , Middle Aged , Pityriasis Lichenoides/complications , Pityriasis Lichenoides/diagnosis , Pityriasis Lichenoides/therapy , Psoriasis/complications , Psoriasis/etiology , Psoriasis/therapy , Methotrexate/administration & dosage , Methotrexate , Biological Therapy/instrumentation , Biological Therapy/methods , Exanthema/complications , Exanthema/diagnosis , Exanthema/therapyABSTRACT
No disponible
Subject(s)
Humans , Male , Infant, Newborn , Porphyria, Erythropoietic/genetics , Bone Marrow Transplantation , Ultraviolet Therapy , Mutation/genetics , Genetic Markers/geneticsABSTRACT
No disponible
Subject(s)
Humans , Male , Adult , Erythema/complications , Erythema/diagnosis , Erythema/drug therapy , Foot Dermatoses/complications , Hand Dermatoses/complications , Leg Dermatoses/complications , Methotrexate/therapeutic use , Acitretin/therapeutic use , Skin Diseases/complications , Skin Diseases/diagnosis , Psoriasis/complications , Psoriasis/diagnosis , Hyperkeratosis, Epidermolytic/complications , Hyperkeratosis, Epidermolytic/therapy , Keratoderma, Palmoplantar/complications , Keratoderma, Palmoplantar/drug therapyABSTRACT
Scedosporium apiospermum is a filamentous fungus that can cause cutaneous or extracutaneous disease. A large number of cases have been published over the last decades, mainly in patients immunocompromised as a result of their disease or treatment. These kinds of infections can progress rapidly and become disseminated, leading to very serious or even fatal complications. We report two new cases of skin infection by Scedosporium apiospermum from our hospital.
Subject(s)
Antifungal Agents/therapeutic use , Dermatomycoses/immunology , Immunocompromised Host , Naphthalenes/administration & dosage , Pyrimidines/administration & dosage , Scedosporium/isolation & purification , Triazoles/administration & dosage , Abscess/drug therapy , Abscess/surgery , Aged , Dermatomycoses/diagnosis , Dermatomycoses/drug therapy , Humans , Male , Scedosporium/drug effects , Terbinafine , VoriconazoleABSTRACT
No disponible
Subject(s)
Adult , Male , Humans , Mycobacterium xenopi/isolation & purification , AIDS-Related Opportunistic Infections , Sacroiliac Joint/microbiology , Arthritis/microbiology , Mycobacterium Infections, Nontuberculous/microbiologyABSTRACT
The evolution (from 1990 to 1996) of fluoroquinolone consumption and resistance and the current patterns of fluoroquinolone usage were examined in a 250-bed community hospital in Spain. Fluoroquinolone consumption increased from 1392 g in 1990 to 3203 g in 1996 (p < 0.05). A significant increase in ciprofloxacin resistance was observed in Escherichia coli isolated from urine samples (from 3 to 20%, p < 0.00001), but not in those E. coli isolated from blood or other sample cultures. In 69 randomly selected clinical charts, fluoroquinolone was used as prophylaxis, empirical therapy, and specific directed therapy in 20%, 65%, and 15%, respectively. Evaluation of quinolone indication was: first choice agents (29%), alternative agents (49%), experimental agents (4.3%) and, agents with no role (1.4%). Our study shows that the increase in the use of fluoroquinolones is associated with the emergence of ciprofloxacin-resistant E. coli from urinary tract sources. Based on their indications, current quinolone usage can be greatly reduced.
